We are live on ! Find out more
Daiwa Securities Group

Daiwa Securities Group Portfolio holdings

AUM $34.8B
1-Year Est. Return 20.7%
This Fund
S&P 500
This Quarter Est. Return
+1.24%
1 Year Est. Return
+20.7%
3 Year Est. Return
+66.64%
5 Year Est. Return
+79.21%
10 Year Est. Return
+192.59%
AUM
$12.1B
AUM Growth
+$312M
Cap. Flow
-$44.8M
Cap. Flow %
-0.37%
Top 10 Hldgs %
38.76%
Holding
1,279
New
83
Increased
328
Reduced
404
Closed
81

Top Buys

Rank Stock Value
1
DLR icon
Digital Realty Trust
DLR
+$239M
2
HR icon
Healthcare Realty
HR
+$179M
3
HST icon
Host Hotels & Resorts
HST
+$129M
4
EXR icon
Extra Space Storage
EXR
+$126M
5
DOC icon
Healthpeak Properties
DOC
+$93.7M

Top Sells

Rank Stock Value
1
SUI icon
Sun Communities
SUI
+$208M
2
CONE
CyrusOne Inc Common Stock
CONE
+$99.4M
3
AMH icon
American Homes 4 Rent
AMH
+$82.5M
4
OHI icon
Omega Healthcare
OHI
+$76.6M
5
PSA icon
Public Storage
PSA
+$68.1M

Sector Composition

Rank Sector Weight
1 Real Estate 72.69%
2 Technology 4.79%
3 Financials 3.72%
4 Healthcare 2.91%
5 Industrials 2.82%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
VYGR icon
1126
Voyager Therapeutics
VYGR
$187M
$3K ﹤0.01%
232
– –
PETQ
1127
DELISTED
PetIQ, Inc. Class A Common Stock
PETQ
$3K ﹤0.01%
136
– –
ORTX
1128
DELISTED
Orchard Therapeutics plc American Depositary Shares
ORTX
$3K ﹤0.01%
+22
New +$2.67K
PRVL
1129
DELISTED
Prevail Therapeutics Inc. Common Stock
PRVL
$3K ﹤0.01%
+192
New +$2.45K
PGNX
1130
DELISTED
Progenics Pharmaceuticals Inc
PGNX
$3K ﹤0.01%
533
– –
BDSI
1131
DELISTED
BioDelivery Sciences International, Inc.
BDSI
$3K ﹤0.01%
+507
New +$2.98K
AUTL
1132
Autolus Therapeutics
AUTL
$389M
$2K ﹤0.01%
168
– –
CLLS
1133
Cellectis
CLLS
$291M
$2K ﹤0.01%
100
– –
CRBP icon
1134
Corbus Pharmaceuticals
CRBP
$168M
$2K ﹤0.01%
14
– –
CTMX icon
1135
CytomX Therapeutics
CTMX
$708M
$2K ﹤0.01%
285
– –
EOLS icon
1136
Evolus
EOLS
$407M
$2K ﹤0.01%
173
– –
INO icon
1137
Inovio Pharmaceuticals
INO
$79.4M
$2K ﹤0.01%
42
– –
LXRX icon
1138
Lexicon Pharmaceuticals
LXRX
$991M
$2K ﹤0.01%
583
– –
MCRB icon
1139
Seres Therapeutics
MCRB
$47M
$2K ﹤0.01%
22
– –
OPTN
1140
DELISTED
OptiNose
OPTN
$2K ﹤0.01%
18
– –
PBYI icon
1141
Puma Biotechnology
PBYI
$407M
$2K ﹤0.01%
243
– –
PRQR icon
1142
ProQR Therapeutics
PRQR
$244M
$2K ﹤0.01%
246
– –
PSNL icon
1143
Personalis
PSNL
$1.28B
$2K ﹤0.01%
+176
New +$1.83K
RIGL icon
1144
Rigel Pharmaceuticals
RIGL
$692M
$2K ﹤0.01%
81
– –
SIGA icon
1145
SIGA Technologies
SIGA
$222M
$2K ﹤0.01%
511
– –
SRRK icon
1146
Scholar Rock
SRRK
$5.86B
$2K ﹤0.01%
+168
New +$1.61K
UBX
1147
DELISTED
Unity Biotechnology
UBX
$2K ﹤0.01%
27
– –
SYRS
1148
DELISTED
Syros Pharmaceuticals, Inc. Common Stock
SYRS
$2K ﹤0.01%
27
– –
GRTS
1149
DELISTED
Gritstone bio, Inc. Common Stock
GRTS
$2K ﹤0.01%
+202
New +$1.68K
EIGR
1150
DELISTED
Eiger BioPharmaceuticals, Inc.
EIGR
$2K ﹤0.01%
4
– –
44 45
46
47 48

Similar funds

SAM
Storebrand Asset Management Lysaker, Norway $34.8B AUM 25.49% 1-Year Est. Return
Chevy Chase Trust
Chevy Chase Trust Bethesda, Maryland $34.7B AUM 29.45% 1-Year Est. Return
William Blair & Company
William Blair & Company Chicago, Illinois $34.9B AUM 18.88% 1-Year Est. Return
VIA
Vanguard Investments Australia Victoria, Australia $34.6B AUM
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return
Parnassus Investments
Parnassus Investments San Francisco, California $34.1B AUM 20.22% 1-Year Est. Return
Kayne Anderson Rudnick Investment Management
Kayne Anderson Rudnick Investment Management Los Angeles, California $34B AUM 6.31% 1-Year Est. Return
Pacer Advisors
Pacer Advisors Malvern, Pennsylvania $35.6B AUM 18.19% 1-Year Est. Return

Daiwa Securities Group's Q4 2019 Portfolio in Review

As of Q4 2019, Daiwa Securities Group held 1,279 positions worth $12.1B, up 2.6% from $11.8B the previous quarter. Its ten largest holdings account for 39% of the portfolio.

Daiwa Securities Group's Q4 2019 filing shows 83 new, 328 increased, 404 reduced and 81 closed positions. Its largest new stake was Performance Food Group: 109,263 shares worth $5.63M. The largest sale was Sun Communities, an estimated $208M.

By sector, the portfolio is most concentrated in Real Estate at 73% of assets, down from 73% a quarter earlier, followed by Technology and Financials.

  • Daiwa Securities Group's largest Q4 2019 buy was Performance Food Group: 109,263 shares worth $5.63M.
  • Daiwa Securities Group added most to Digital Realty Trust in Q4 2019, an estimated $239M increase.
  • Daiwa Securities Group's biggest Q4 2019 reduction was Sun Communities, cutting an estimated $208M.
  • Daiwa Securities Group fully exited State Street SPDR S&P 500 ETF Trust in Q4 2019, selling an estimated $13.1M.
  • Daiwa Securities Group's ten largest holdings make up 39% of its $12.1B portfolio in Q4 2019.
  • Daiwa Securities Group opened 83 new positions and closed 81 in Q4 2019.
  • Daiwa Securities Group's portfolio value rose 2.6% quarter-over-quarter to $12.1B.

Based on Daiwa Securities Group's 13F filing for Q4 2019, filed 31 Jan 2020.